Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Avidity Biosciences (RNA) Long-Term Debt Issuances (2019)

Avidity Biosciences (RNA) has disclosed Long-Term Debt Issuances for 1 consecutive years, with -$7000.0 as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Long-Term Debt Issuances changed N/A year-over-year to -$7000.0, compared with a TTM value of -$7000.0 through Dec 2020, changed N/A, and an annual FY2019 reading of $19.5 million, up 550.97% over the prior year.
  • Long-Term Debt Issuances was -$7000.0 for Q3 2019 at Avidity Biosciences, down from $4.5 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $4.5 million in Q2 2019 and bottomed at -$7000.0 in Q3 2019.